#33: NewsBot: PANC Stock: Panacos Announces Results of Bevirimat Prospective Study, which Confirm Patient Response Predictors
Completed Phase 2b Extension Study Determines Likely Phase 3 Patient
... |
June 19, 2008
06:27:15 PM |
#32: NewsBot: Panacos Announces Results of Bevirimat 350 mg Cohort, Data Support Further Dose Escalation in Phase 2b Study
Company to Hold a Conference Call at 5:00 p.m. EST Today
Panacos... |
December 12, 2007
06:03:01 AM |
#31: FastFun: Panacos to Report Third Quarter Results for 2007
Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company... |
October 26, 2007
09:08:27 AM |
#30: FastFun: Panacos Announces Management Changes
Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company... |
October 26, 2007
09:07:58 AM |
#29: NewsBot: PANC News Panacos Announces Bevirimat Phase 2b Dose Escalation Strategy
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a... |
March 12, 2007
01:02:00 PM |
#28: NewsBot: PANC News Panacos to Present at Citigroup Small & Mid-Cap Conference
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq: PANC), a... |
March 8, 2007
05:51:00 AM |
#27: NewsBot: PANC News Panacos to Present at Cowen Health Care Conference
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a... |
March 6, 2007
05:35:00 AM |
#26: NewsBot: PANC News Panacos Begins Phase 1 Clinical Study of Second Generation Maturation Inhibitor PA-040
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a... |
February 27, 2007
05:41:00 AM |
#25: NewsBot: PANC News Panacos Reports Fourth Quarter and Full Year 2006 Financial Results
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a... |
February 21, 2007
01:02:00 PM |
#24: NewsBot: PANC News Panacos to Report Fourth Quarter and Year-End Results for 2006
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a... |
February 14, 2007
01:00:00 PM |
#23: NewsBot: PANC News Panacos Appoints Dr. Tom Lategan, Vice President of Regulatory Affairs
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a... |
February 14, 2007
05:00:00 AM |
#22: NewsBot: PANC News Panacos Appoints Alan W. Dunton, M.D. as New CEO
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a... |
January 8, 2007
05:00:00 AM |
#21: NewsBot: PANC News Panacos to Present at 2007 JPMorgan Healthcare Conference
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a... |
January 3, 2007
05:00:00 AM |
#20: NewsBot: PANC News Panacos Files IND for Second-Generation Maturation Inhibitor
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq: PANC), a... |
December 21, 2006
01:02:00 PM |
#19: NewsBot: PANC News Panacos Announces First Cohort Results of Phase 2b Study
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a... |
December 19, 2006
01:02:00 PM |
| 
| 
| 
| 
| 
| 
